0001815974 EX-FILING FEES SC TO SC TO-I 0001815974 2025-12-22 2025-12-22 0001815974 1 2025-12-22 2025-12-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Schedule TO-I

(Form Type)

 

Anebulo Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Transaction Valuation

 

   Transaction Valuation   Fee rate  

Amount of

Filing Fee

 
Fees to Be Paid  $1,050,000 (1)   0.00013810 (2)  $145.01 (2)
Fees Previously Paid  $-    -   $- 
Total Transaction Valuation  $1,050,000           
Total Fees Due for Filing            $145.01 
Total Fees Previously Paid            $- 
Total Fee Offsets            $- 
Net Fee Due            $145.01 

 

(1) Estimated solely for purposes of calculating the filing fee. This amount is based on the offer to purchase up to 300,000 shares of common stock, par value $0.001 per share, at the tender offer price of $3.50 per share.
   
(2) The amount of the filing fee, calculated in accordance with Rule 0-11(b) under the Securities Exchange Act of 1934, as amended, equals $138.10 per $1,000,000 of the value of the transaction.